Clinical trial
Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled Trial
NCT03130127 is registered in ClinicalTrials.gov with General Hospital of Shenyang Military Region as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Continuous Versus Bolus Infusion of Terlipressin for Portal Hypertension Related Bleeding in Liver Cirrhosis: A Prospective Non-randomized Controlled Trial
- Lead sponsor
- General Hospital of Shenyang Military Region
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 1, 2024
- Completion date
- December 1, 2025
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
bleeding, esophageal and gastric varices, liver cirrhosis, portal hypertension, variceal hemorrhage